tiprankstipranks
Trending News
More News >
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
NASDAQ:KNSA
US Market

Compare Kiniksa Pharmaceuticals (KNSA) vs. Competitors

Compare
549 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Kiniksa Pharmaceuticals
$43.92
$3.33B
99.62
120.93%
5 Buy
0 Hold
0 Sell
Strong Buy
Beam Therapeutics
$27.62
$2.80B
-6.30
1.25%
10 Buy
3 Hold
0 Sell
Strong Buy
Disc Medicine
$77.32
$2.92B
-15.05
39.06%
12 Buy
0 Hold
0 Sell
Strong Buy
Harmony Biosciences Holdings
$36.52
$2.10B
11.92
-7.64%
4 Buy
0 Hold
1 Sell
Moderate Buy
Centessa Pharmaceuticals
$24.57
$3.30B
-13.84
45.30%
13 Buy
0 Hold
0 Sell
Strong Buy
CG Oncology, Inc.
$52.05
$4.20B
-27.39
72.64%
13 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KNSA
Kiniksa Pharmaceuticals
43.92
25.04
132.63%
BEAM
Beam Therapeutics
27.62
2.03
7.93%
IRON
Disc Medicine
77.32
22.33
40.61%
HRMY
Harmony Biosciences Holdings
36.52
-2.18
-5.63%
CNTA
Centessa Pharmaceuticals
24.57
7.67
45.38%
CGON
CG Oncology, Inc.
52.05
22.69
77.28%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts